Published by Josh White on 22nd December 2022
(Sharecast News) - Cannabis-based medicine developer Celadon Pharmaceuticals updated the market on its application for registration of its West Midlands facility with the UK Medicines and Healthcare products Regulatory Agency (MHRA) for the 'Good Manufacturing Practices' (GMP) approval of its cannabis active pharmaceutical ingredient (API).